Ann Hynes
Stock Analyst at Mizuho Securities
(4.65)
# 854
Out of 5,022 analysts
1138
Total ratings
58.9%
Success rate
8.2%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Reiterated: Hold | $264 → $295 | $290.19 | +1.66% | 16 | Sep 25, 2026 | |
| EHC Encompass Health | Reiterated: Buy | $134 → $140 | $119.80 | +16.86% | 42 | Aug 11, 2026 | |
| MD Pediatrix Medical Group | Reiterated: Hold | $27 → $28 | $25.97 | +7.82% | 46 | Aug 11, 2026 | |
| CON Concentra Group Holdings Parent | Reiterated: Buy | $35 → $40 | $35.65 | +12.20% | 11 | Aug 10, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $320 → $355 | $308.49 | +15.08% | 62 | Aug 10, 2026 | |
| THC Tenet Healthcare | Reiterated: Buy | $250 → $290 | $258.62 | +12.13% | 54 | Aug 10, 2026 | |
| ARDT Ardent Health | Reiterated: Buy | $12 → $13 | $10.34 | +25.73% | 8 | Aug 6, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $86 | $60.25 | +42.74% | 21 | Jul 31, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Hold | $16 → $19 | $20.00 | -5.00% | 16 | Jul 31, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $230 → $275 | $258.21 | +6.50% | 53 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $233.33 | +11.43% | 65 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 → $475 | $426.69 | +11.32% | 64 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $665 | $599.47 | +10.93% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 → $493 | $371.90 | +32.56% | 57 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $31 | $28.06 | +10.48% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 → $69 | $62.99 | +9.54% | 38 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $86.46 | +38.79% | 74 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $465 → $470 | $386.43 | +21.63% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $468 | $388.36 | +20.51% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 → $255 | $189.54 | +34.54% | 36 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $13.32 | +42.64% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $200 | $175.72 | +13.82% | 62 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $190 | $162.02 | +17.27% | 53 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $330 → $340 | $270.53 | +25.68% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $309.05 | n/a | 38 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $902.28 | n/a | 52 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 | $228.30 | n/a | 43 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $220 | $124.12 | n/a | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $552.26 | n/a | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.74 | n/a | 1 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.6 | $2.72 | n/a | 16 | Jul 27, 2018 |
Charles River Laboratories International
Sep 25, 2026
Reiterated: Hold
Price Target: $264 → $295
Current: $290.19
Upside: +1.66%
Encompass Health
Aug 11, 2026
Reiterated: Buy
Price Target: $134 → $140
Current: $119.80
Upside: +16.86%
Pediatrix Medical Group
Aug 11, 2026
Reiterated: Hold
Price Target: $27 → $28
Current: $25.97
Upside: +7.82%
Concentra Group Holdings Parent
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $35.65
Upside: +12.20%
Labcorp Holdings
Aug 10, 2026
Reiterated: Buy
Price Target: $320 → $355
Current: $308.49
Upside: +15.08%
Tenet Healthcare
Aug 10, 2026
Reiterated: Buy
Price Target: $250 → $290
Current: $258.62
Upside: +12.13%
Ardent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $10.34
Upside: +25.73%
BrightSpring Health Services
Jul 31, 2026
Reiterated: Buy
Price Target: $86
Current: $60.25
Upside: +42.74%
Fortrea Holdings
Jul 31, 2026
Reiterated: Hold
Price Target: $16 → $19
Current: $20.00
Upside: -5.00%
IQVIA Holdings
Jul 31, 2026
Reiterated: Buy
Price Target: $230 → $275
Current: $258.21
Upside: +6.50%
Jul 28, 2026
Reiterated: Buy
Price Target: $260
Current: $233.33
Upside: +11.43%
Jul 28, 2026
Reiterated: Buy
Price Target: $525 → $475
Current: $426.69
Upside: +11.32%
Jul 28, 2026
Reiterated: Buy
Price Target: $665
Current: $599.47
Upside: +10.93%
Jul 21, 2026
Reiterated: Buy
Price Target: $470 → $493
Current: $371.90
Upside: +32.56%
Jul 13, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $28.06
Upside: +10.48%
Jul 13, 2026
Reiterated: Hold
Price Target: $63 → $69
Current: $62.99
Upside: +9.54%
Jul 13, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $86.46
Upside: +38.79%
Jul 13, 2026
Reiterated: Buy
Price Target: $465 → $470
Current: $386.43
Upside: +21.63%
Jul 13, 2026
Reiterated: Buy
Price Target: $390 → $468
Current: $388.36
Upside: +20.51%
Jul 13, 2026
Reiterated: Buy
Price Target: $215 → $255
Current: $189.54
Upside: +34.54%
Jul 13, 2026
Reiterated: Buy
Price Target: $17 → $19
Current: $13.32
Upside: +42.64%
Jul 13, 2026
Reiterated: Buy
Price Target: $230 → $200
Current: $175.72
Upside: +13.82%
Jun 26, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $162.02
Upside: +17.27%
Jun 8, 2026
Reiterated: Buy
Price Target: $330 → $340
Current: $270.53
Upside: +25.68%
Mar 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $309.05
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $902.28
Upside: n/a
Nov 4, 2024
Rated: Hold
Price Target: $110
Current: $228.30
Upside: n/a
Nov 8, 2022
Reiterated: Hold
Price Target: $220
Current: $124.12
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $552.26
Upside: n/a
Apr 11, 2022
Reiterated: Buy
Price Target: n/a
Current: $63.74
Upside: n/a
Jul 27, 2018
Reiterated: Hold
Price Target: $4.5 → $3.6
Current: $2.72
Upside: n/a